8-K/AOther Events

QUEST DIAGNOSTICS INC 8-K/A Report (May 1, 2003)

Filed May 1, 2003For Securities:DGX

Summary

This filing is an amendment (Form 8-K/A) to a previous report filed on February 26, 2003, specifically amending Item 7 which pertains to financial statements and schedules. The primary purpose of this amendment is to provide investors with the financial details of the acquired company, Unilab Corporation, and pro forma combined financial information for Quest Diagnostics. This updated disclosure is crucial for understanding the financial impact of the Unilab acquisition on Quest Diagnostics' balance sheet and income statement as of year-end 2002 and for the fiscal year 2002. Investors should focus on the included financial statements of Unilab Corporation for the years ended December 31, 2002, 2001, and 2000, as well as the unaudited pro forma combined financial statements for Quest Diagnostics as of December 31, 2002, and for the year then ended. These documents will allow for an assessment of the acquired business's historical performance and the combined entity's projected financial position and operational results following the acquisition. The filing implicitly confirms the acquisition of Unilab Corporation has occurred and is being formally reported with its associated financial data.

Key Highlights

  • 1Amendment to a previous 8-K filing, specifically revising Item 7 regarding financial information.
  • 2Provides the financial statements of Unilab Corporation for the years ending December 31, 2002, 2001, and 2000.
  • 3Includes unaudited pro forma combined balance sheet for Quest Diagnostics as of December 31, 2002.
  • 4Includes unaudited pro forma combined statement of operations for Quest Diagnostics for the year ended December 31, 2002.
  • 5This filing facilitates investor understanding of the financial impact of the Unilab Corporation acquisition.
  • 6The report's earliest event date is February 26, 2003, with the amendment filed on May 1, 2003.

Frequently Asked Questions

This filing is an amendment to a previous 8-K report. Its main purpose is to provide investors with the complete financial statements of the acquired company, Unilab Corporation, and pro forma combined financial information for Quest Diagnostics, reflecting the impact of the Unilab acquisition.

The filing includes the financial statements of Unilab Corporation for the fiscal years ending December 31, 2002, 2001, and 2000. This allows investors to review the historical performance of the acquired entity.

The unaudited pro forma combined financial statements show Quest Diagnostics' financial position and results as if the acquisition of Unilab Corporation had occurred at an earlier date (specifically, for the balance sheet as of December 31, 2002, and for the statement of operations for the year then ended). It helps investors understand the combined entity's financial picture post-acquisition.

The financial statements of Unilab Corporation are filed as Exhibit 99.1, and the pro forma combined financial information is filed as Exhibit 99.2 to this Form 8-K/A.